1

Christian Kullmann, Chairman of the Executive Board of Evonik Industries AG

Charts to the statement at theAnnual Shareholders’ Meeting in Essen (Germany)on August 31, 2020, 10 a.m.

2

Deliverycapability

SocialResponsibility

Health ! High standards of hygiene at our sites! Comprehensive pandemic plan

! Company-wide team to ensure availability to deliver! Timely action to counter bottlenecks

! Supply of desinfectants! Donation of high-performance polymers for medical-grade protective equipment

Dealing with the coronavirus crisis at Evonik

3

New divisional structure from 1 July 2020

Divestment of the cyclicalmethacrylates business

in 2019

PeroxyChem and Porocelto further strengthen

the quality of our portfolio

Further optimization of cost basis Acquisitions

Desinvestment

Chemical operative segmentstransferred in four divisionswith clear strategic roles

SG&A Program to reduce sellingand administrative expenses –

€ 20 m ahead of plan in 2019

Strategy implementation over the last 20 months

4

€ 13,108million

Sales Adjusted EBITDA Adjusted earnings per share

€ 2,153million

€ 1.94

Strong operating performance in 2019

5

Resource EfficiencyNutrition & Care Performance Materials

7284,582

15.9

Sales(in € million)

Adj. EBITDA (in € million)/ margin (in %)

1,2905,685

22.7

Sales (in € million)

Adj. EBITDA (in € million)/ margin (in %)

2242,043

11.0

Sales (in € million)

Adj. EBITDA (in € million)/ margin (in %)

Segment operating performance in 2019

6

! Dividend policy aligned tocontinuity and reliability

! Dividend yield of over 4 %among the bestin the chemical industry

1

1.15

201720122008 2009 20132010 2015

1.15

2011 2014 2016 2018 2019

+7 %CAGR

Dividend (in €)

Stable dividend and high dividend yield of over 4 percent

1 Proposal including the advance payment

7

€ 2,153 m

2019 2020E

€ 1.7 bn

€ 2.1 bn

Outlook 2020 – earnings between € 1.7 bn and € 2.1 bn expected

8

! Operating performance of the first half-year impacted by coronavirus crisis

! Nutrition & Care and Resource Efficiency largely stable! Performance Materials held back by drop in the oil price

! Sales: € 6,069 m! Adjusted EBITDA: € 970 m! Adjusted earnings per share: € 0.73

1st half-year 2020 – largely stable performance of our growth segments

9

1 Definition of the peers in the chemicals sector: Arkema, BASF, Covestro, Clariant, DSM, Lanxess, Solvay

Price performance 2019Evonik: +25% Peers in the chemicals sector1: +29%MDAX: +28%

Price performance 2020Evonik: –9% Peers in the chemicals sector1: –10%MDAX: –5%

212223242526272829

Jan 19 Mar 19 May 19 Jul 19 Sep 19 Nov 1915

17

19

21

23

25

27

29

Jan 20 Mar 20 May 20 Jul 20

Evonik shares – price performance in 2019 and 2020

10